Molecular signatures of anti-nuclear antibodies - Contribution of heavy chain framework residues

Peter Sedrak, Kelvin Hsu, Chandra Mohan

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

It is clear that besides the CDR residues, framework residues (particularly those on FR1 and FR3) can contribute towards antigen reactivity. This study was designed to compare the immunoglobulin heavy chain FR regions of anti-nuclear antibodies (comprised of 142 anti-ssDNA, 103 anti-dsDNA and 23 anti-nucleosome Abs) with those of non-nuclear antibodies (N=165), all drawn from the GenBank. The anti-nuclear antibodies depicted residue-usage differences that reached statistical significance in their FR1 (at H1 and H29), FR2 (at H40), and FR3 (at H69, H73, H76, H80 and H87) regions. Interestingly, these residue-usage differences were intimately linked to differences in the usage frequencies of different VH germline genes between the different groups of antibodies; thus, whereas J558.4, J558.47, J558.m, and 7183.9 germline genes were over-utilized among the ANAs, J558.17, V130, V H 36-60 and VGk1a were over-represented among the non-ANAs. In conclusion, although the framework regions of ANAs exhibited distinctly different residue-usage patterns, they may simply be markers of associated germline-encoded CDR differences that appear to have been co-selected. Further studies are warranted to ascertain if any of the observed framework residue differences do actually contribute to nuclear antigen reactivity.

Original languageEnglish (US)
Pages (from-to)491-499
Number of pages9
JournalMolecular Immunology
Volume40
Issue number8
DOIs
StatePublished - Dec 2003

Fingerprint

Anti-Idiotypic Antibodies
Nuclear Antigens
Immunoglobulin Heavy Chains
Nucleosomes
Antibodies
Nucleic Acid Databases
Genes
Antigens

Keywords

  • Anti-DNA
  • Framework
  • Immunoglobulin
  • Lupus
  • Repertoire

ASJC Scopus subject areas

  • Molecular Biology
  • Immunology

Cite this

Molecular signatures of anti-nuclear antibodies - Contribution of heavy chain framework residues. / Sedrak, Peter; Hsu, Kelvin; Mohan, Chandra.

In: Molecular Immunology, Vol. 40, No. 8, 12.2003, p. 491-499.

Research output: Contribution to journalArticle

Sedrak, Peter ; Hsu, Kelvin ; Mohan, Chandra. / Molecular signatures of anti-nuclear antibodies - Contribution of heavy chain framework residues. In: Molecular Immunology. 2003 ; Vol. 40, No. 8. pp. 491-499.
@article{888a961a013c468b9153e28bde620587,
title = "Molecular signatures of anti-nuclear antibodies - Contribution of heavy chain framework residues",
abstract = "It is clear that besides the CDR residues, framework residues (particularly those on FR1 and FR3) can contribute towards antigen reactivity. This study was designed to compare the immunoglobulin heavy chain FR regions of anti-nuclear antibodies (comprised of 142 anti-ssDNA, 103 anti-dsDNA and 23 anti-nucleosome Abs) with those of non-nuclear antibodies (N=165), all drawn from the GenBank. The anti-nuclear antibodies depicted residue-usage differences that reached statistical significance in their FR1 (at H1 and H29), FR2 (at H40), and FR3 (at H69, H73, H76, H80 and H87) regions. Interestingly, these residue-usage differences were intimately linked to differences in the usage frequencies of different VH germline genes between the different groups of antibodies; thus, whereas J558.4, J558.47, J558.m, and 7183.9 germline genes were over-utilized among the ANAs, J558.17, V130, V H 36-60 and VGk1a were over-represented among the non-ANAs. In conclusion, although the framework regions of ANAs exhibited distinctly different residue-usage patterns, they may simply be markers of associated germline-encoded CDR differences that appear to have been co-selected. Further studies are warranted to ascertain if any of the observed framework residue differences do actually contribute to nuclear antigen reactivity.",
keywords = "Anti-DNA, Framework, Immunoglobulin, Lupus, Repertoire",
author = "Peter Sedrak and Kelvin Hsu and Chandra Mohan",
year = "2003",
month = "12",
doi = "10.1016/S0161-5890(03)00223-2",
language = "English (US)",
volume = "40",
pages = "491--499",
journal = "Molecular Immunology",
issn = "0161-5890",
publisher = "Elsevier Limited",
number = "8",

}

TY - JOUR

T1 - Molecular signatures of anti-nuclear antibodies - Contribution of heavy chain framework residues

AU - Sedrak, Peter

AU - Hsu, Kelvin

AU - Mohan, Chandra

PY - 2003/12

Y1 - 2003/12

N2 - It is clear that besides the CDR residues, framework residues (particularly those on FR1 and FR3) can contribute towards antigen reactivity. This study was designed to compare the immunoglobulin heavy chain FR regions of anti-nuclear antibodies (comprised of 142 anti-ssDNA, 103 anti-dsDNA and 23 anti-nucleosome Abs) with those of non-nuclear antibodies (N=165), all drawn from the GenBank. The anti-nuclear antibodies depicted residue-usage differences that reached statistical significance in their FR1 (at H1 and H29), FR2 (at H40), and FR3 (at H69, H73, H76, H80 and H87) regions. Interestingly, these residue-usage differences were intimately linked to differences in the usage frequencies of different VH germline genes between the different groups of antibodies; thus, whereas J558.4, J558.47, J558.m, and 7183.9 germline genes were over-utilized among the ANAs, J558.17, V130, V H 36-60 and VGk1a were over-represented among the non-ANAs. In conclusion, although the framework regions of ANAs exhibited distinctly different residue-usage patterns, they may simply be markers of associated germline-encoded CDR differences that appear to have been co-selected. Further studies are warranted to ascertain if any of the observed framework residue differences do actually contribute to nuclear antigen reactivity.

AB - It is clear that besides the CDR residues, framework residues (particularly those on FR1 and FR3) can contribute towards antigen reactivity. This study was designed to compare the immunoglobulin heavy chain FR regions of anti-nuclear antibodies (comprised of 142 anti-ssDNA, 103 anti-dsDNA and 23 anti-nucleosome Abs) with those of non-nuclear antibodies (N=165), all drawn from the GenBank. The anti-nuclear antibodies depicted residue-usage differences that reached statistical significance in their FR1 (at H1 and H29), FR2 (at H40), and FR3 (at H69, H73, H76, H80 and H87) regions. Interestingly, these residue-usage differences were intimately linked to differences in the usage frequencies of different VH germline genes between the different groups of antibodies; thus, whereas J558.4, J558.47, J558.m, and 7183.9 germline genes were over-utilized among the ANAs, J558.17, V130, V H 36-60 and VGk1a were over-represented among the non-ANAs. In conclusion, although the framework regions of ANAs exhibited distinctly different residue-usage patterns, they may simply be markers of associated germline-encoded CDR differences that appear to have been co-selected. Further studies are warranted to ascertain if any of the observed framework residue differences do actually contribute to nuclear antigen reactivity.

KW - Anti-DNA

KW - Framework

KW - Immunoglobulin

KW - Lupus

KW - Repertoire

UR - http://www.scopus.com/inward/record.url?scp=0141918821&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141918821&partnerID=8YFLogxK

U2 - 10.1016/S0161-5890(03)00223-2

DO - 10.1016/S0161-5890(03)00223-2

M3 - Article

C2 - 14563368

AN - SCOPUS:0141918821

VL - 40

SP - 491

EP - 499

JO - Molecular Immunology

JF - Molecular Immunology

SN - 0161-5890

IS - 8

ER -